Literature DB >> 20938702

Diagnostic value of procalcitonin in pleural effusions.

C-Y Wang1, Y-C Hsiao, J-S Jerng, C-C Ho, C-C Lai, C-J Yu, P-R Hsueh, P-C Yang.   

Abstract

This study was to determine the diagnostic value of procalcitonin (PCT) in the differentiation of infectious and non-infectious causes of pleural effusion. From January 2005 to April 2005, we measured the PCT levels of pleural effusion from 76 patients using an immunoluminometric assay. The types of pleural infusions studied were para-pneumonic effusion (n = 26), empyema (n = 7), tuberculous pleurisy (n = 8), malignant pleural effusion (n = 25) and transudative pleural effusion (n = 8). The PCT levels were low in transudative pleural effusions (0.188 ± 0.077 ng/mL) and tuberculous pleurisy (0.130 ± 0.069 ng/mL), but high in empyema (5.147 ± 3.056 ng/mL), para-pneumonic effusion (1.091 ± 0.355 ng/mL), and malignant pleural effusion (0.241 ± 0.071 ng/mL). The receiver-operating characteristic curve analysis for an optimal discrimination between empyema and para-pneumonic effusion from non-para-pneumonic effusion could be performed at a cut-off point of 0.18 ng/mL with area under the curve of 0.776 (sensitivity: 69.7%, specificity: 72.1%). The correlation was found between pleural effusion PCT and serum PCT levels in 16 patients (r² = 0.967, p < 0.001). In conclusion, a high pleural effusion PCT level suggests the presence of empyema and para-pneumonic effusion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938702     DOI: 10.1007/s10096-010-1082-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

Review 1.  Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors.

Authors:  K L Becker; E S Nylén; J C White; B Müller; R H Snider
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

2.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

3.  Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin.

Authors:  F M Brunkhorst; O K Eberhard; R Brunkhorst
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

4.  Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP.

Authors:  K Nyamande; U G Lalloo
Journal:  Int J Tuberc Lung Dis       Date:  2006-05       Impact factor: 2.373

5.  Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy.

Authors:  Erdinc Cakir; Omer Deniz; Omer Ozcan; Ergun Tozkoparan; Halil Yaman; Emin Ozgur Akgul; Cumhur Bilgi; Hayati Bilgic; Kudret Ekiz; Mehmet Kemal Erbil
Journal:  Clin Biochem       Date:  2005-03       Impact factor: 3.281

6.  Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.

Authors:  Ching-Lung Liu; Wen-Yeh Hsieh; Chien-Liang Wu; Hsu-Tah Kuo; Yen-Ta Lu
Journal:  Respir Med       Date:  2006-11-13       Impact factor: 3.415

7.  Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion.

Authors:  Ming-Cheng Chan; Kai-Ming Chang; Wen-Cheng Chao; Liang-Yi Lin; Benjamin Ing-Tiau Kuo; Jeng-Yuan Hsu; Chieh-Liang Wu
Journal:  Respirology       Date:  2007-05       Impact factor: 6.424

8.  Tumor markers in pleural effusions.

Authors:  O Topolcan; L Holubec; V Polivkova; S Svobodova; M Pesek; V Treska; J Safranek; T Hajek; L Bartunek; M Rousarova; J Finek
Journal:  Anticancer Res       Date:  2007 Jul-Aug       Impact factor: 2.480

9.  Biomarkers of infection for the differential diagnosis of pleural effusions.

Authors:  J M Porcel; M Vives; G Cao; S Bielsa; A Ruiz-González; A Martínez-Iribarren; A Esquerda
Journal:  Eur Respir J       Date:  2009-06-18       Impact factor: 16.671

10.  Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

View more
  7 in total

Review 1.  Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.

Authors:  Justin L Wong; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-03-01       Impact factor: 2.878

2.  Performance of procalcitonin in diagnosing parapneumonic pleural effusions: A clinical study and meta-analysis.

Authors:  Chao He; Bo Wang; Danni Li; Huan Xu; Yongchun Shen
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

3.  The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions.

Authors:  Naoki Watanabe; Tomoya Ishii; Nobuyuki Kita; Nobuhiro Kanaji; Hiroyuki Nakamura; Nobuki Nanki; Yutaka Ueda; Yasunori Tojo; Norimitsu Kadowaki; Shuji Bandoh
Journal:  BMC Pulm Med       Date:  2018-11-23       Impact factor: 3.317

4.  Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings.

Authors:  Fiona J McCann; Stephen J Chapman; Wai Cho Yu; Nick A Maskell; Robert J O Davies; Y C Gary Lee
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

5.  Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients.

Authors:  Segal Abdul Aziz; Erni Juwita Nelwan; Lugyanti Sukrisman; Suhendro Suhendro
Journal:  BMC Res Notes       Date:  2018-01-30

6.  Combination of procalcitonin, C-reaction protein and carcinoembryonic antigens for discriminating between benign and malignant pleural effusions.

Authors:  Mingde Ji; Xiaofei Zhu; Jie Dong; Shining Qian; Fei Meng; Wanjian Gu; Wen Qiu
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

7.  Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.

Authors:  Anita Sharma; Apurva Agrawal; Girish Sindhwani; Ashish Sharma; Sojit Tomo; Jaykaran Charan; Dharmveer Yadav; Praveen Sharma
Journal:  Pleura Peritoneum       Date:  2021-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.